investor presentation post asx news: imugene and eureka therapeutics oncarlytics collaboration
Published 2 years ago • 2.2K plays • Length 26:56Download video MP4
Download video MP3
Similar videos
-
8:29
imugene's leslie chong details eureka therapeutics collaboration
-
4:12
imugene's ceo interviewed on ausbiz detailing a clinical trial deal with merck germany and pfizer.
-
9:16
imugene ceo leslie chong presents at wholesale investor's virtual showcase july 2020
-
18:08
asx/ausbiz biotech unlocked with imugene ceo leslie chong
-
5:30
stock of the day: liontown resources (ltr)
-
6:17
bull market won't be derailed, rockefeller's chang says
-
12:34
中國降準、降息救經濟 銀行業逾4萬人被裁員、離職|主持人 劉姿麟|華視國際線,出發!|說新聞 20240929
-
44:28
imugene investor presentation | non-deal roadshow 2023 australia
-
6:29
imugene finishes phase 1a monotherapy dose escalation of pd1 vaxx
-
9:34
imugene (asx: imu) – first patient dosed in checkvacc phase 1 trials
-
29:19
imugene celularity announce an exclusive strategic partnership to develop a novel oncolytic virus.
-
3:50
strategist: strong short-term momentum for china stocks, but we prefer markets with visible growth
-
2:07
cerebras files for ipo
-
5:15
imugene featured on behind the scenes with host laurence fishburne.
-
4:11
imugene limited (asx: imu) | snn network
-
4:36
tokyo shares plunge as investors rethink outlook under ishibaーnhk world-japan news
-
6:40
imugene doses first patient in vaxinia phase 1 trial
-
5:10
imugene welcomes new chief medical officer and talks significant new patents
-
0:36
imugene's science series: checkvacc with professor yuman fong and dr. yuan yuan.
-
6:41
australian foundation investment company (asx:afi) fy24 full-year results